ARENA, FLAVIA

Nome completo

ARENA, FLAVIA

Afferenza

DIPARTIMENTO DI SCIENZE CLINICO-CHIRURGICHE, DIAGNOSTICHE E PEDIATRICHE

Mostra records

Risultati 1 - 8 di 8 (tempo di esecuzione: 0.013 secondi).

A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study

2021-01-01 Lasagna, A; Agustoni, F; Percivalle, E; Borgetto, S; Paulet, A; Comolli, G; Sarasini, A; Bergami, F; Sammartino, J C; Ferrari, A; Zavaglio, F; Arena, F; Lilleri, D; Secondino, S; Falzoni, M; Schiavo, R; Klersy, C; Lo Cascio, G; Cavanna, L; Baldanti, F; Pedrazzoli, P; Cassaniti, I

Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up

2022-01-01 Lasagna, A; Lilleri, D; Agustoni, F; Percivalle, E; Borgetto, S; Alessio, N; Comolli, G; Sarasini, A; Bergami, F; Sammartino, J C; Ferrari, A; Zavaglio, F; Arena, F; Secondino, S; Falzoni, M; Schiavo, R; Lo Cascio, G; Cavanna, L; Baldanti, F; Pedrazzoli, P; Cassaniti, I

Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers

2022-01-01 Bergami, F.; Arena, F.; Sammartino, J. C.; Ferrari, A.; Zavaglio, F.; Zelini, P.; Paolucci, S.; Comolli, G.; Percivalle, E.; Lilleri, D.; Cassaniti, I.; Baldanti, F.

Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients

2022-01-01 Cassaniti, I.; Gregorini, M.; Bergami, F.; Arena, F.; Sammartino, J. C.; Percivalle, E.; Soleymaninejadian, E.; Abelli, M.; Ticozzelli, E.; Nocco, A.; Minero, F.; Pattonieri, E. F.; Lilleri, D.; Rampino, T.; Baldanti, F.

Human Cytomegalovirus (HCMV) - specific T-cell response after letermovir prophylaxis is predictive for subsequent HCMV reactivation in haematopoietic stem cell transplant recipients

2023-01-01 Zavaglio, F.; Vitello, D.; Bergami, F.; Arena, F.; Borsani, O.; Colombo, A. A.; Caldera, D.; Lilleri, D.; Cassaniti, I.; Bernasconi, P.; Baldanti, F.

Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment

2022-01-01 Lasagna, A.; Bergami, F.; Lilleri, D.; Percivalle, E.; Quaccini, M.; Comolli, G.; Sarasini, A.; Sammartino, J. C.; Ferrari, A.; Arena, F.; Cicognini, D.; Schiavo, R.; Lo Cascio, G.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I.

Immune response to bnt162b2 in solid organ transplant recipients: Negative impact of mycophenolate and high responsiveness of sars-cov-2 recovered subjects against delta variant

2021-01-01 Cassaniti, I.; Bergami, F.; Arena, F.; Sammartino, J. C.; Ferrari, A.; Zavaglio, F.; Curti, I.; Percivalle, E.; Meloni, F.; Pandolfi, L.; Pellegrini, C.; Turco, A.; Seminari, E.; Pattonieri, E. F.; Gregorini, M.; Rampino, T.; Sarasini, A.; Lilleri, D.; Baldanti, F.

Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern

2022-01-01 Lasagna, A.; Bergami, F.; Lilleri, D.; Percivalle, E.; Quaccini, M.; Serra, F.; Comolli, G.; Sarasini, A.; Sammartino, J. C.; Ferrari, A.; Arena, F.; Secondino, S.; Cicognini, D.; Schiavo, R.; Lo Cascio, G.; Cavanna, L.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I.

Titolo	Data di pubblicazione	Autore(i)
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study	1-gen-2021	Lasagna, A; Agustoni, F; Percivalle, E; Borgetto, S; Paulet, A; Comolli, G; Sarasini, A; Bergami, F; Sammartino, J C; Ferrari, A; Zavaglio, F; Arena, F; Lilleri, D; Secondino, S; Falzoni, M; Schiavo, R; Klersy, C; Lo Cascio, G; Cavanna, L; Baldanti, F; Pedrazzoli, P; Cassaniti, I
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up	1-gen-2022	Lasagna, A; Lilleri, D; Agustoni, F; Percivalle, E; Borgetto, S; Alessio, N; Comolli, G; Sarasini, A; Bergami, F; Sammartino, J C; Ferrari, A; Zavaglio, F; Arena, F; Secondino, S; Falzoni, M; Schiavo, R; Lo Cascio, G; Cavanna, L; Baldanti, F; Pedrazzoli, P; Cassaniti, I
Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers	1-gen-2022	Bergami, F.; Arena, F.; Sammartino, J. C.; Ferrari, A.; Zavaglio, F.; Zelini, P.; Paolucci, S.; Comolli, G.; Percivalle, E.; Lilleri, D.; Cassaniti, I.; Baldanti, F.
Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients	1-gen-2022	Cassaniti, I.; Gregorini, M.; Bergami, F.; Arena, F.; Sammartino, J. C.; Percivalle, E.; Soleymaninejadian, E.; Abelli, M.; Ticozzelli, E.; Nocco, A.; Minero, F.; Pattonieri, E. F.; Lilleri, D.; Rampino, T.; Baldanti, F.
Human Cytomegalovirus (HCMV) - specific T-cell response after letermovir prophylaxis is predictive for subsequent HCMV reactivation in haematopoietic stem cell transplant recipients	1-gen-2023	Zavaglio, F.; Vitello, D.; Bergami, F.; Arena, F.; Borsani, O.; Colombo, A. A.; Caldera, D.; Lilleri, D.; Cassaniti, I.; Bernasconi, P.; Baldanti, F.
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment	1-gen-2022	Lasagna, A.; Bergami, F.; Lilleri, D.; Percivalle, E.; Quaccini, M.; Comolli, G.; Sarasini, A.; Sammartino, J. C.; Ferrari, A.; Arena, F.; Cicognini, D.; Schiavo, R.; Lo Cascio, G.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I.
Immune response to bnt162b2 in solid organ transplant recipients: Negative impact of mycophenolate and high responsiveness of sars-cov-2 recovered subjects against delta variant	1-gen-2021	Cassaniti, I.; Bergami, F.; Arena, F.; Sammartino, J. C.; Ferrari, A.; Zavaglio, F.; Curti, I.; Percivalle, E.; Meloni, F.; Pandolfi, L.; Pellegrini, C.; Turco, A.; Seminari, E.; Pattonieri, E. F.; Gregorini, M.; Rampino, T.; Sarasini, A.; Lilleri, D.; Baldanti, F.
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern	1-gen-2022	Lasagna, A.; Bergami, F.; Lilleri, D.; Percivalle, E.; Quaccini, M.; Serra, F.; Comolli, G.; Sarasini, A.; Sammartino, J. C.; Ferrari, A.; Arena, F.; Secondino, S.; Cicognini, D.; Schiavo, R.; Lo Cascio, G.; Cavanna, L.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I.